Aroa’s Symphony may hit the right note in RFK Jnr's Medicare overhaul

Aroa’s Symphony may hit the right note in RFK Jnr's Medicare overhaul
Aroa chief executive Brian Ward says the company is encouraged by planned changes to Medicare billing for skin substitutes. (Image: NZME/Getty/Jacques Steenkamp/Supplied)
Rebecca Stevenson
Auckland-based med tech firm Aroa could be the winner from proposed changes to how the United States' Medicare pays for outpatient wound care, a new report says. Aroa, which is listed on the ASX, utilises sheep stomachs to produce wound repair products that aid in healing chronic wounds, hernias, soft tissue injuries, and for breast reconstruction. A new report by Wilsons Advisory said Aroa Biosurgery was best placed to gain from the Centers for Medicare and Medicaid Services’ (CMS) draft proposal to pay a flat rate for...

More Markets

NZ sharemarket up 0.3% despite business confidence drop
Markets Market Close

NZ sharemarket up 0.3% despite business confidence drop

The S&P/NZX 50 Index closed at 13,531.29, up 42.05 points or 0.31%.

ASB settles CCCFA class action for hefty $135.6m
Finance

ASB settles CCCFA class action for hefty $135.6m

 It ended a four-year class action centred on disclosure obligations.

ASB pays $135.6m to settle long-running CCCFA class action
Finance

ASB pays $135.6m to settle long-running CCCFA class action

High-street lender ASB has agreed to pay $135.6 million to settle a class action brought against it for alleged breaches of the Credit Contracts and Consumer Finance Act (CCCFA).The settlement – without admission of liability or wrongdoing – concluded four years of legal proceedi...